c-LEcta GmbH
Pierre Aldag is a professional with extensive experience in project management and research in the field of biophysics. Currently serving as Head of Project Management and Executive Assistant to the CEO at c-LEcta GmbH since October 2021, Pierre previously held a PhD candidacy focused on CRISPR-Cas enzymes at the University of Leipzig from October 2016 to September 2021. Additional experience includes a role as Research Development Intern at uniQure and positions as a Student Assistant at RWTH Aachen University and Helmholtz-Institut, where research was conducted on irreversible electroporation. Pierre holds a Master of Business Administration from HHL Leipzig Graduate School of Management, a Master of Science in Physics from RWTH Aachen University, and a Bachelor of Science in Physics from the same institution, along with an Erasmus exchange at Paris-Sud University.
This person is not in any teams
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.